Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer.
- DOI
- 10.21037/jgo-2026-1-0024
- Published
- 2026 Apr 30
- Container
- Journal of gastrointestinal oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/jgo-2026-1-0024,
title = {Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer.},
author = {Shin E and Lee HS and Eom DW and Kwak JY and Yang KM and Oh HS and Kim S and Yu CS},
year = {2026},
journal = {Journal of gastrointestinal oncology},
doi = {10.21037/jgo-2026-1-0024},
url = {https://doi.org/10.21037/jgo-2026-1-0024}
}RIS
TY - JOUR TI - Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer. AU - Shin E AU - Lee HS AU - Eom DW AU - Kwak JY AU - Yang KM AU - Oh HS AU - Kim S AU - Yu CS PY - 2026 JO - Journal of gastrointestinal oncology DO - 10.21037/jgo-2026-1-0024 UR - https://doi.org/10.21037/jgo-2026-1-0024 ER -
APA
E, S., HS, L., DW, E., JY, K., KM, Y., HS, O., S, K., & CS, Y. (2026). Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer.. Journal of gastrointestinal oncology. https://doi.org/10.21037/jgo-2026-1-0024
Source records
- pubmed · retrieved 2026-09-26T13:15:30.985Z